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Abstract 
 
Objective: To investigate whether patients requiring dialysis are a higher risk 
surgical population and would experience more peri-operative adverse events 
even when undergoing a perceived less invasive operation as a laparoscopic 
radical nephrectomy (LRN).  LRN is generally a well-tolerated surgical procedure 
with minimal morbidity and mortality. Prior to transplantation, dialysis patients will 
often have to undergo a LRN to remove a native kidney with a suspicious mass. 
 
Materials and Methods: Patients in the American College of Surgeons National 
Surgical Quality Improvement Program who underwent a laparoscopic radical 
nephrectomy between 2011 and 2016 were included. Patients were stratified by 
the need for pre-operative dialysis two weeks prior to surgery, and peri-operative 
outcomes were compared. A multivariable logistic regression analysis was 
performed to test the association between the need for pre-operative dialysis and 
peri-operative risk. 
 
Results: There were 8,315 patients included in this analysis of which 445 (5.4%) 
patients required pre-operative dialysis. Patients who required pre-operative 
dialysis had more minor (p < .0001) and major (p=.0025) complications, a higher 
rate of return to the operating room (p=0.002), and a longer length of stay (LOS) 
(p < 0.0001) than those patients not requiring pre-operative dialysis. In a 
multivariate analysis, the need for pre-operative dialysis was independently 
associated with adverse peri-operative outcomes (OR=1.45, CI=1.08-1.95, 
p=.015). 
 
Conclusions: Patients requiring pre-operative dialysis were more likely to 
experience a peri-operative complication and have a longer LOS. For LRNs 
performed prior to transplantation, further risk stratification is needed, and 
treatment sequencing may need to be reconsidered. 
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Introduction 
 
Surgery is the cornerstone of treatment for localized renal tumors suspected to be 
renal cell carcinoma.1 Whether radical or partial nephrectomy, excision of localized 
renal masses results in very high cure rates with low patient morbidity and mortality.2 
End-stage renal disease is a risk factor for the development of renal cancer in 
patients’ native kidneys, however studies have shown that these tumors, often 
acquired cystic kidney cancer,3 have an indolent course.4-5 Often, patients 
undergoing a renal transplantation evaluation will be found to have tumors in their 
native kidneys,6 and the clinical challenge will arise as to whether these tumors 
should be removed prior to, at the time of, or after transplantation. Some transplant 
centers will require that the native kidney with a tumor be removed prior to 
transplantation to establish a histologic diagnosis in order to risk stratify the patient’s 
cancer, if present. 
Chronic kidney disease has been shown to have significant negative health 
consequences in many settings.7-10 Peri-operatively, chronic kidney disease and/or 
end-stage renal disease has been correlated with adverse surgical outcomes.11-12 
Furthermore, the negative health correlation between increasing age and end-stage 
renal disease is quite dramatic.13 Although minimally-invasive surgery is often 
considered to be almost “risk-free”, there is evidence demonstrating that laparoscopic 
procedures can carry a significant risk for complications in vulnerable populations, 
such as patients with end-stage renal disease.14-15 Thus, there may exist a false 
sense of security in performing laparoscopic radical nephrectomies in patients with 
localized renal masses who have end-stage renal disease requiring renal 
replacement therapy.  
In this study, we sought to evaluate the effect of the need for pre-operative dialysis 
on patients undergoing laparoscopic radical nephrectomy (LRN). We hypothesized 
that although a relatively well-tolerated and low complication surgery, the need for 
pre-operative dialysis would have a significant impact on peri-operative outcomes 
and hospital length of stay on patients undergoing a LRN.  
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Methods 
Data for this study were obtained from the American College of Surgeons 
National Surgical Quality Improvement Program (ACS-NSQIP). The NSQIP 
database collects information from patients’ post-surgery from participating 
institutions. Post-operative complications, preoperative health data, and 
demographic information are collected to allow for complete analysis and 
outcome assessment. For this study, patients between the years 2011 to 2016 
were identified by the Current Procedural Terminology code for laparoscopic 
nephrectomy (50545). Demographic information, health status, and outcomes 
information for these patients were collected. Study patients were stratified by the 
need for pre-operative dialysis, a variable captured in NSQIP as the status of 
renal function at least 2 weeks prior to surgery. Due to the uncertainty whether 
their renal failure was due to surgical complications or unresolved previous 
health concerns, patients who reported renal failure requiring dialysis within 30 
days post-operatively were excluded from the study. After exclusions for missing 
data, the total study population that was analyzed was 8,315. 
For patients undergoing a laparoscopic nephrectomy during the study period, 
information was collected on patient demographics, comorbidities, American 
Society of Anesthesiologists (ASA) score, smoking history, functional status and 
BMI. The age of patients was then divided into different age categories (<40, 40-
49, 50-59, ≥60) as well as BMI (<18.5 = underweight, 18.5–25= normal weight, 
25–30 = overweight, and obese = >30). Estimated GFR was also calculated and 
recorded for non-dialysis patients. Patient demographic data were then evaluated 
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for significance against status of pre-operative dialysis using the Chi-square test 
of association or Fischer’s exact test. 
The outcomes of interest for this study were reported complications that occurred 
within 30 days or less after surgery, length of postsurgical hospital stay, and 
return to operating room within 30 days of surgery. Each complication was 
grouped uniformly into a grade of severity based on the Clavien-Dindo 
classification as either minor (I-II), major (III-IV), or death (V). ACS-NSQIP 
reported complications include: superficial incisional skin infection, pneumonia, 
pulmonary embolus, urinary tract infection (UTI), transfusion, deep vein 
thrombosis (DVT), deep incisional skin infection, wound infection, re-intubation, 
failure to wean off ventilator more than 48 hours post operation, cardiovascular 
accident (CVA), cardiac arrest, myocardial infarction (MI), sepsis, and death. 
Fischer’s Exact test was used to determine statistical significance of each 
complication against dialysis status. To further assess for univariate differences 
in complication rates among patients stratified by dialysis status and grouped into 
severity levels, the Cochran-Armitage test for trends was applied. 
After adjusting for comorbidity burden, a multivariate ordinal regression analysis 
was performed to test for association between pre-operative dialysis status and 
complication severity, hospital length of stay, and return to operating room within 
30 days. A p-value of less than 0.05 was considered statistically significant. All 
statistical analysis was performed using SAS version 9.4 software. 
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Results 
8,315 patients were included in this analysis. Of the total cohort, 61.2% of the 
patients were male, and 85.9% were Caucasian. Stratified by the pre-operative 
variable of needing dialysis two weeks prior to surgery, there were 445 (5.4%) 
patients who required pre-operative dialysis while the remaining 7,870 (94.6%) 
patients did not. 
Significant differences existed between the two populations. (Table 1) Patients who 
were dialysis-dependent were more likely to be male (p < 0.0001), younger than 60 
years of age (p < 0.0001), and non-Caucasian (p < .0001). Also, dialysis patients had 
higher pre-operative rates of diabetes, hypertension, and CHF (all p < 0.0001), 
expected co-morbidities which are causative of and often co-exist with end-stage 
renal disease. The dialysis dependent group also had a higher rate of ASA scores 
above 3 (p < .0001) compared to the non-dialysis group. There was no statistically 
significant difference in the rates of smoking, functional status, or COPD between 
groups. Median baseline eGFR for patients not on dialysis was 77.5 mL/min 
(IQR=62.1 – 92.8 mL/min).  
Tables 2 and 3 collate the type and frequency, stratified by Clavien grade, of post-
operative complications between the two groups. In the dialysis group, 17.5% of 
patients had a minor complication, and 7.6% of patients had a major complication. 5 
(1.1%) patients in this group died within 30 days of surgery. In the non-dialysis group, 
9.9% and 3.0% of patients had a minor and major complication, respectively. 35 
(0.4%) patients in this group died within the 30 days of surgery. The most common 
minor and major complications in the two groups were the need for a blood 
transfusion (12.1% in pre-operative dialysis group v. 5.8% in no pre-operative dialysis 
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group) and unplanned reintubation (2.0% in the pre-operative dialysis group and 
0.74% in the no pre-operative dialysis group) (both complications had p-values < 
0.05). Patients who required pre-operative dialysis had more minor (p < .0001) and 
major (p=.0025) complications than those patients not requiring pre-operative 
dialysis. The death rate between the two groups approached statistical significance 
(p=0.06), i.e, patients requiring pre-operative dialysis had a statistically higher 
likelihood of dying post-operatively when compared to those not requiring pre-
operative dialysis. 
Finally, 17 (3.8%) patients in the pre-operative dialysis group had an unplanned 
return to the OR within 30 days after surgery compared to 131 (1.7%) patients in the 
non-dialysis group (p=0.002). The median and mean length of stay in patients 
requiring pre-operative dialysis were 3 and 4.2 days (range=0-44 days); and, the 
median and mean length of stay in patients not requiring pre-operative dialysis were 
3 and 3.3 days (range=0-73 days), respectively. The mean LOS was significantly 
longer in patients requiring pre-operative dialysis (p < 0.0001). Also, patients who 
required pre-operative dialysis were more likely to have a length of stay greater than 
4 days than those patients not needing pre-operative dialysis (27.2% versus 16.5%, 
p < .0001). 
The results of the multivariable logistic regression analysis identifying factors 
associated with peri-operative outcomes are displayed in Table 4. The presence of 
diabetes, CHF, ASA score above 3,, and pre-operative dialysis were all associated 
with an increasing risk of complications post-operatively. Patients needing pre-
operative dialysis had a higher likelihood of having an adverse peri-operative event 
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than those not requiring dialysis (OR=1.45, CI=1.08-1.95, p=0.015). Interestingly, 
being obese appeared to have an independently protective effect against peri-
operative events in this analysis (OR=0.68, CI=0.55-1.43, p=0.002).
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Discussion 
Our study of 8,315 patients who underwent a LRN revealed that patients needing 
pre-operative dialysis had higher rates of adverse peri-operative events 
compared to those patients not requiring pre-operative dialysis. Statistically 
significant higher rates of minor and major complications were noted in the 
dialysis dependent group.  We also found higher rates of blood transfusions, 
unplanned re-intubations, and unplanned return to the operating room in the 30-
day post-operative period for the LRN group.  Length of stay was also 
significantly longer for the dialysis dependent group as compared to the control 
group, however this post-operative outcome may be inherently biased since 
many dialysis patients may have required longer stays in the hospital due to their 
dialysis requirements or schedule. 
Our findings are well supported by the literature on this topic.  A study utilizing 
NSQIP data from 2005 to 2008 looked at over 165,000 patients who underwent 
major general surgeries.  Of these patients, 1506 or 0.9% were dialysis 
dependent.  The dialysis dependent patients had higher overall complications, 
higher rates of return to the operating room, and longer lengths of stay.  These 
complications were broken down into higher rates of pulmonary complications 
including pneumonia, unplanned intubation, and ventilator dependence as well 
as higher rates of death.16   
With all the aforementioned complications and adverse outcomes in this patient 
population, one may question must justify the need for performing LRN. in this 
patient population.  Research suggests that ESRD patients have higher rates of 
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renal masses, however these masses seem to appear to have a more indolent 
course than renal tumors in non-dialysis patients. In a study of 1,250 patients 
with renal cell carcinoma (RCC), T stage, metastatic disease, nodal invasion, and 
Fuhrman nuclear grade were all statistically significantly lower in the ESRD 
patient population compared to non ESRD patient population. Finally, cancer-
specific mortality rates were lower in the ESRD patient population.17 
Traditionally, the predominant histologic subtype in the ESRD population has 
been reported as papillary RCC.  However, a recent study of 27 patients with 
ESRD who underwent a radical nephrectomy between 1994 and 2008 found 
lower rates of papillary RCC.  This study found the most common tumor type to 
be acquired cystic disease (ACD)-associated RCC accounting for 44% of the 
tumors.  Papillary RCC was identified in only 11% of the tumors.18  A separate 
study of 66 renal masses in ESRD patients revealed papillary RCC to constitute 
only 18% (12/66) of the tumors while ACD-associated RCC comprised 36% 
(24/66) of the tumors.19   
Others have looked at the clinical significant of ACD-associated RCC.  In a 
recent study of forty patients with ACD-associated RCC, clinical follow up was 
available for 36 patients with a mean follow-up length of 27 months.  The vast 
majority 32/36 (89%) had no evidence of disease on follow-up.  This included 24 
patients (67%) who were alive with no evidence of disease recurrence, 4 patients 
(11%) who were deceased from other causes, and 4 patients (11%) who had 
died of unknown causes.  Four patients did have recurrences with 2 patients 
(6%) having local recurrences and 2 patients (6%) developing metastases.  Of 
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the four patients with recurrence, 3 out of 4 were staged at pT3a.  Three of four 
tumors were ISUP grade 3 while the remaining tumor was ISUP grade 4.20  While 
the true nature of ACD-associated RCC necessitates further study, the low 
metastatic potential of renal masses found in the ESRD patient population seems 
well-supported.21 Nevertheless, given the data suggesting that ESRD patients 
have a biologically less aggressive form of kidney cancer, it is important to 
remember that many patients will develop papillary and clear cell tumors that will 
act in a similar manner to the non-ESRD population.   
Given the known higher mortality and morbidity rate of operating on the dialysis 
dependent patient as well as lower T stage and Fuhrman grade noted in those 
found to have a renal mass, some urologists may question the necessity of or 
timing of treatment.  Data are lacking as to the long-term outcomes of active 
surveillance in the small renal mass dialysis dependent patient population.  A 
recent survey of active transplant centers in the United States revealed that 59% 
of participants felt that the preferred treatment entailed a radical nephrectomy 
followed by active surveillance in 21.3% of the respondents. Of the 
correspondents whose institutions did not allow active surveillance, 77.4% would 
monitor small renal masses following transplantation if shown safety of active 
surveillance.22 
There are several limitations to our study.  The NSQIP database collects patient 
information up to thirty days following surgery.  Complications, including deaths, 
which occur after this period are not collected, potentially under-estimating 
adverse events.  In addition, there is no pathologic variables abstracted thus 
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limiting our ability to comment on the indolence versus aggressiveness or types 
of tumors seen in this patient population as well as the indications for surgery. 
Finally, there is an inherent limitation in all large, administrative databases in that 
we are dependent on the accurate and reliable input of the data. Nevertheless, 
despite these acknowledged limitations of the data, the size of this dataset and 
the unique clinical variables collected allow for the examination of clinical 
scenarios as presented in this manuscript.    
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Conclusions 
Our study of over 8,000 patients appears to demonstrate that the dialysis-
dependent patient population is complex and faces higher morbidity and mortality 
rates when compared to non-dialysis dependent patients undergoing a LRN. The 
true aggressiveness of ACD-associated RCC has not been well defined but 
seems to be more indolent in nature compared to spontaneous renal masses in 
the non-ESRD population.  With the higher surgical risks and possibly more 
indolent nature of renal masses in this patient population, the role of active 
surveillance or delayed nephrectomy until after successful renal transplantation 
may be a more prudent approach. 
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Table 1: Pre-operative descriptive characteristics of study 
population 
 Dialysis  
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**eGFR reported as median (Q1-Q3). Students t-test used to test for significance 
for baseline eGFR in non-dialysis patients. Mean eGFR = 79.1.  
  
 Yes (n=445) 
n (%) 
No (n=7,870) 
n (%) 
 
P-value 
Sex    
 Male 312 (70.1) 4,776 (60.7) <.0001 
 Female 133 (29.9) 3,094 (39.3)  
*Age    
 <40 27 (6.1) 411 (5.3) <.0001 
 40-49 64 (14.4) 784 (10.0)  
 50-59 134 (30.1) 1,845 (23.6)  
 ≥60 220 (49.4) 4,787 (61.2)  
*Race    
 Caucasian 202 (48.8) 5,924 (88.2) <.0001 
 African 
American 
186 (44.9) 588 (8.8)  
 Asian 19 (4.6) 162 (2.4)  
 Other 7 (1.7) 42 (1.7)  
*ASA Scores    
 ≤3 253 (57) 7,474 (95) <.0001 
 4 191 (43) 383 (4.9)  
 5 0 1 (<0.1)  
Median estimated 
GFR 
N/A **77.5 mL/min 
(IQR = 62.1-
92.8) 
-- 
Diabetes 141 (31.7) 1,637 (20.8) <.0001 
COPD 24 (5.4) 440 (5.6) 1.00 
CHF 14 (3.1) 56 (0.7) <.0001 
Hypertension 378 (84.9) 5,045 (64.1) <.0001 
Smoking 73 (16.4) 1,568 (19.9) 0.076 
Functional Status    
 Independent 430 (96.6) 7,714 (98.0) 0.100 
 Partially 
Independent 
11 (2.5) 119 (1.5)  
 Totally 
dependent 
2 (0.5) 9 (0.1)  
 Unknown 2 (0.5) 28 (0.4)  
*BMI    
 Underweight 8 (1.8) 77 (1.0) 0.006 
 Normal Weight 100 (22.5) 1,392 (17.8)  
 Overweight 160 (36.0) 2,724 (34.8)  
 Obese 176 (39.6) 3,643 (46.5)  
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TABLE 2: COMPLICATIONS CAPTURED BY NSQIP BY PROCEDURE  
  DIALYSIS   
COMPLICATION GRADE BY 
CALVIEN-DINDO INDEX 
Yes 
n (%) 
No 
n (%) 
 
P-value 
MINOR    
 SUPERFICIAL INCISIONAL 
INFECTION 
8 (1.8) 81 (1.0) 0.147 
 PNEUMONIA 10 (2.2) 64 (0.8) 0.006 
 PULMONARY EMBOLUS NA 25 (0.3) 0.642 
 UTI 3 (0.7) 114 (1.5) 0.216 
 BLOOD TRANSFUSION 54 (12.1) 457 (5.8) <.0001 
 DEEP VEIN THROMBOSIS 3 (0.7) 36 (0.5) 0.464 
 TOTAL 78 777  
MAJOR    
 DEEP INCISIONAL 
INFECTION 
NA 6 (0.1) 1.00 
 ORGAN SPACE WOUND 
INFECTION 
4 (0.9) 27 (0.3) 0.081 
 WOUND DEHISCENCE 3 (0.7) 31 (0.4) 0.427 
 REINTUBATION 9 (2.0) 58 (0.7) 0.009 
 VENTILATOR >48 HOURS 3 (0.7) 27 (0.3) 0.215 
 CARDIOVASCULAR 
ACCIDENT 
2 (0.5) 11 (0.1) 0.151 
 CARDIAC ARREST 5 (1.1) 12 (0.2) <.0001 
 MYOCARDIAL 
INFARCTION 
6 (1.4) 31 (0.4) 0.013 
 SEPSIS 2 (0.5) 34 (0.4) 0.719 
 TOTAL 34 237  
DEATH 5 (1.1) 35 (0.4) 0.061 
*Only highest grade complication accounted for per patient  
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TABLE 3: COMPLICATION ACCORDING TO STATUS OF 
DIALYSIS 
 DIALYSIS 
COMPLICATION 
GRADE 
Yes 
n (%) 
No 
n (%) 
P-value 
 
NONE 355 (79.8) 7,028 (89.3) <.0001 
MINOR 65 (14.6) 639 (8.1) <.0001 
MAJOR 20 (4.5) 168 (2.1)   0.0025 
DEATH 5 (1.1) 35 (0.4)   0.0605 
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TABLE 4: MULTIVARIATE REGRESSION 
 Odds Ratio 95% CI P-value 
SEX    
 FEMALE 1.00 -- -- 
 MALE 0.86 1.01 – 
1.35 
0.051 
AGE    
 <40 1.00 -- -- 
 40-49 1.03 0.66 – 
1.53 
0.990 
 50-59 0.88 0.60 – 
1.28 
0.487 
 ≥60 1.09 0.77 – 
1.56 
0.626 
RACE    
 CAUCASIAN 1.00 -- -- 
 AFRICAN AMERICAN 0.93 0.73 – 
1.19 
0.557 
 ASIAN 0.88 0.54 – 
1.43 
0.601 
 OTHER 0.82 0.32 – 
2.09 
0.672 
PRE-OPERATIVE 
RENAL FAILURE 
1.45 1.08 – 
1.95 
0.015 
DIABETES 1.29 1.08 – 
1.54 
0.006 
CHF 2.38 1.36 – 
4.16 
0.002 
HYPERTENSION 1.17 0.98 – 
1.40 
0.083 
ASA STATUS    
    ≤3 1.00 -- -- 
 4 2.19 1.71 –
2.80 
<.0001 
 5 N/A N/A N/A 
SMOKING 0.83 0.68 – 
1.02 
0.075 
FUNCTIONAL STATUS    
 INDEPENDENT 1.00 -- -- 
 PARTIALLY 
INDEPENDENT 
2.82 1.84 – 
4.33 
<.0001 
 TOTALLY 
DEPENDENT 
N/A N/A N/A 
BMI    
 NORMAL 1.00 -- -- 
 UNDERWEIGHT 0.55 0.24 – 0.144 
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1.23 
 OVERWEIGHT 0.90 0.73 – 
1.10 
0.298 
 OBESE 0.68 0.55 – 
1.43 
0.002 
